Fifty1 Labs与Lunr Aerospace达成战略合作,共同开创AI驱动的太空医学药物再利用技术。此次合作旨在利用人工智能和轨道通道技术,革新宇航员健康解决方案,目标在2032年实现20亿美元的市场规模。
Fifty1 Labs与Lunr Aerospace达成战略合作,共同开创AI驱动的太空医学药物再利用技术。此次合作旨在利用人工智能和轨道通道技术,革新宇航员健康解决方案,目标在2032年实现20亿美元的市场规模。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.